Dakota Wealth Management Moderna, Inc. Transaction History

Dakota Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$101.21 - $166.61 $708 - $1,166	7 Added 0.22%	3,254 $386,000
Q1 2024 Apr 24, 2024	BUY	$85.37 - $115.44 $277,196 - $374,833	3,247 New	3,247 $346,000
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $125,827 - $233,874	-995 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $3.53 Million - $5.77 Million	-15,650 Reduced 94.02%	995 $253,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $3.69 Million - $8.06 Million	16,645 New	16,645 $6.41 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Dakota Wealth Management with notifications on news.